Table 2.
Deceased donor and recipient characteristics according to DGF status
| ALL (n=902) | DGF (n=291) | No DGF (n=611) | P* | ||
|---|---|---|---|---|---|
| Recipient Characteristics | |||||
| Age, years | 54 (44, 63) | 53 (45, 62) | 55 (44, 63) | 0.73 | |
| Male | 561 (62%) | 194 (67%) | 367 (60%) | 0.056 | |
| Black race | 392 (43%) | 161 (55%) | 231 (38%) | <0.001 | |
| Previous kidney transplant | 118 (13%) | 39 (13%) | 79 (13%) | 0.84 | |
| Cause of ESRD | Other or unknown | 206 (23%) | 58 (20%) | 148 (24%) | 0.20 |
| Diabetes | 262 (29%) | 85 (29%) | 177 (29%) | ||
| Hypertension | 238 (26%) | 90 (31%) | 148 (24%) | ||
| GN | 148 (16%) | 42 (14%) | 106 (17%) | ||
| Graft failure | 48 (5%) | 16 (5%) | 32 (5%) | ||
| Panel reactive antibody | 0% | 578 (64%) | 188 (65%) | 390 (64%) | 0.52 |
| 1–20% | 58 (6%) | 22 (8%) | 36 (6%) | ||
| 21–80% | 119 (13%) | 40 (14%) | 79 (13%) | ||
| >80% | 147 (16%) | 41 (14%) | 106 (17%) | ||
| Pre-transplant dialysis | 794 (88%) | 279 (96%) | 515 (84%) | <0.001 | |
| Body mass index | 27.4 (23.8, 31.6) | 28.2 (24.4, 33.1) | 26.9 (23.5, 30.9) | <0.001 | |
| Duration of dialysis before transplant, months | 44.6 (15.8, 67.8) | 56.7 (32.5, 75.8) | 38.1 (9.0, 62.0) | <0.001 | |
| HLA mismatch level | 5 [4, 5] | 5 [4, 5] | 5 [4, 5] | 0.029 | |
| Cold ischemia time, hours | 14 [10, 18.5] | 15.4 [11.7, 20.3] | 13 [9.3, 17.4] | <0.001 | |
| Kidney machine perfused | 317 (35%) | 131 (45%) | 186 (30%) | <0.001 | |
| Donor Characteristics | |||||
| Age, years | 40 [26, 51] | 45 [30, 53] | 36 [24, 50] | <0.001 | |
| Male | 597 (66%) | 201 (69%) | 396 (65%) | 0.21 | |
| Black race | 155 (17%) | 52 (18%) | 103 (17%) | 0.71 | |
| Extended criteria donor | 139 (15%) | 52 (18%) | 87 (14%) | 0.16 | |
| Donation after cardiac death | 139 (15%) | 74 (25%) | 65 (11%) | <0.001 | |
| Kidney donor profile index, % | 43 [21, 67] | 54 [35, 70] | 37 [18, 62] | <0.001 | |
| CVA as cause of death | 318 (35%) | 119 (41%) | 199 (33%) | 0.014 | |
| Acute kidney injury | 216 (24%) | 95 (33%) | 121 (20%) | <0.001 | |
| Terminal serum creatinine, mg/dl | 0.9 [0.7, 1.3] | 1.04 [0.7, 1.5] | 0.9 [0.7, 1.2] | 0.003 | |
DGF, Delayed Graft Function; ESRD, End Stage renal Disease; CVA, cerebral vascular accident; GN, Glomerulonephritis; HLA, Human Leukocyte Antigen. Statistics reported are median [IQR] or n (%).
*
Wilcoxon rank sum test for continuous variables and chi square test for categorical variables.